Medical Oxygen Concentrators Market to reach USD 7.0 Billion by 2035 at 6.26% CAGR

Medical Oxygen Concentrators Market to Grow from USD 3.815 Bn in 2025 to USD 7.0 Bn by 2035-By Rising Respiratory Disease Prevalence, Home Healthcare Shift

NY, CA, UNITED STATES, September 18, 2026 /EINPresswire.com/ -- As per Market Research Future, the global Medical Oxygen Concentrators Market size is projected to reach USD 7.0 Billion by 2035 from USD 3.815 Billion in 2025, at a CAGR of 6.26% during the forecast period 2025--2035. The market base was estimated at USD 3.59 Billion in 2024.

The 6.26% CAGR---anchored by structural shifts in respiratory care delivery---is propelled by three converging forces: the rising global prevalence of chronic respiratory diseases, with COPD affecting approximately 392 million people worldwide according to the IHME Global Burden of Disease Study, driving healthcare providers to increasingly adopt oxygen concentrators for long-term oxygen therapy and home-based management; advancements in device technology, particularly portable, lightweight designs and smart connectivity options, which significantly improve patient mobility, adherence, and quality of life; and the integration of digital health technologies, including remote monitoring platforms and telehealth services, that enhance patient management, therapy outcomes, and decentralized healthcare delivery.

Global medical device companies and health organizations are amplifying this momentum. Philips continues driving innovation through smart oxygen concentrators with portable and energy-efficient designs, strengthened by continuous R&D investments and digital health integration. Invacare is expanding its homecare oxygen solutions portfolio through acquisitions and product diversification in respiratory devices. AirSep has focused on regulatory-compliant oxygen concentrator systems with enhanced safety and performance standards. According to IHME data, chronic respiratory diseases contribute to over 454 million cases globally, while COPD accounts for more than 3 million deaths annually. These forces are creating the clinical infrastructure and patient demand on which the Medical Oxygen Concentrators Market depends.

Request A Free Sample:

https://www.marketresearchfuture.com/sample_request/7876

Key Market Trends & Growth Drivers

Rising Demand for Home Healthcare Solutions

The market is witnessing an increasing demand for home-based oxygen therapy options. As healthcare systems recognize home care as a cost-effective alternative to hospital stays, more patients are seeking effective home-use respiratory devices. According to the World Health Organization (WHO), over 50% of healthcare services for chronic diseases are increasingly delivered at home, while healthcare costs can be reduced by up to 30% through home-based care. This trend indicates a shift in care delivery towards decentralized models, with oxygen concentrators being recognized for their role in enhancing patient independence. Invacare continues advancing product development through compact oxygen concentrators designed for long-term patient use.

Advancements in Device Technology

Innovations in oxygen concentrator design are becoming a hallmark of the industry. Manufacturers are exploring various technological enhancements, including improved portability, energy efficiency, and smart connectivity features. These advancements aim to enhance patient compliance and convenience, potentially leading to better therapy adherence and increased market penetration. Portable oxygen concentrators accounted for approximately 63% of the market in 2024, driven by mobility, convenience, and patient-friendly respiratory support.

Integration of Digital Health and Remote Monitoring

The incorporation of digital technologies into oxygen therapy is gaining traction. Tools such as mobile applications for monitoring oxygen levels and remote patient management platforms are being utilized to track therapy adherence and facilitate timely clinical interventions. Philips continues investing in digital health integration and remote monitoring solutions, improving patient adherence and therapy outcomes across its respiratory care portfolio.

Increasing Prevalence of Respiratory Disorders

The rising incidence of respiratory disorders is a primary driver. According to IHME, chronic respiratory diseases contribute to over 454 million cases globally, with COPD accounting for more than 3 million deaths annually, significantly driving demand for oxygen therapy devices. The market is projected to expand as healthcare providers increasingly prescribe oxygen concentrators to manage chronic respiratory conditions. According to CDC data, over 16 million Americans are diagnosed with COPD, underscoring the urgent need for accessible oxygen therapy solutions.

Ask for Customization:

https://www.marketresearchfuture.com/ask_for_customize/7876

Market Segment Insights

BY PRODUCT TYPE

Portable Oxygen Concentrators: Largest segment with 63% share, driven by mobility, convenience, and patient-friendly respiratory support systems. Philips continues expanding its portable portfolio through sustained product innovation in energy-efficient designs.

Stationary Oxygen Concentrators: Valued at USD 2.09 Billion in 2024, the highest-valuation single segment, appealing to patients who prefer a more robust unit for continuous home use.

BY TECHNOLOGY

Continuous Flow: Largest segment with 66% share, driven by reliable oxygen delivery for chronic respiratory disease patients globally. Valued at USD 2.15 Billion in 2024.

Pulse Dose: Fastest-growing technology, valued at USD 1.44 Billion in 2024, gaining traction due to its innovative delivery mechanism and efficiency during specific activities.

BY INDICATION

COPD: Largest segment with 61% share, supported by IHME reporting approximately 392 million global COPD patients requiring oxygen therapy.

Asthma: Fastest-growing indication, projected to reach USD 1.5 Billion by 2035, as respiratory disease management continues to expand.

Sleep Apnea: Significant share, reflecting growing diagnosis rates and home-based treatment adoption.

Others: Smaller but notable share, indicating niche interest across additional respiratory conditions.

BY END USER

Hospitals and Clinics: Largest segment with 58% share, reflecting their essential role in providing immediate care to patients with respiratory difficulties, catering to both acute and chronic conditions.

Homecare Settings: Fastest-growing end user, driven by rising preferences for at-home treatment options, technological innovations enhancing mobility and usability, and growing demand for remote monitoring and personalized healthcare solutions.

Read Detailed Insights:

https://www.marketresearchfuture.com/reports/medical-oxygen-concentrators-market-7876

Regional Outlook

North America --- Market Leader in Innovation

North America leads with over 40% of global revenue in 2024, generating around USD 1.44 Billion. The region's growth is driven by an aging population, increasing prevalence of respiratory diseases, and advancements in technology. According to CDC data, over 16 million Americans are diagnosed with COPD, significantly contributing to oxygen therapy demand. The competitive landscape is characterized by key oxygen machine manufacturers such as Invacare, AirSep, and OxyGo, focusing on innovative product development and strategic partnerships.

Europe --- Second Largest Market

Europe was valued at USD 1.08 Billion in 2024, representing the second-largest regional market with a 30% share. The region benefits from increasing incidence of chronic respiratory diseases and supportive regulatory frameworks, with the European Medicines Agency (EMA) facilitating the approval of innovative medical devices. Leading countries include Germany, France, and the UK, where major players such as Philips and Drive DeVilbiss Healthcare are prominent.

Asia-Pacific --- Rapidly Growing Market Segment

The Asia-Pacific region accounts for about 25% of the global share. The growth is driven by rising healthcare expenditures, increasing awareness of respiratory health, and a growing elderly population. China accounts for 36% of the regional market valued at USD 0.32 Billion, driven by a large patient base, while Japan holds 24% share valued at USD 0.21 Billion, supported by technological advancements and aging demographics. The competitive landscape features key players such as Nidek Medical and GCE Group.

Middle East and Africa --- Untapped Potential

The MEA region holds around 5% of the global share, driven by increasing awareness of respiratory health issues and government initiatives aimed at enhancing healthcare access. Saudi Arabia holds 37% of the regional market valued at USD 0.07 Billion, driven by healthcare investments, while South Africa holds 26% share valued at USD 0.05 Billion, supported by improving respiratory care infrastructure. Countries like South Africa and the UAE are leading the way, with a growing presence of international players.

Competitive Landscape and Recent Developments

The Medical Oxygen Concentrators Market is characterized by dynamic competition and steady technological advancement, driven by increasing demand for home healthcare solutions worldwide. The global industry appears moderately fragmented, with several key players exerting significant influence through innovation and regional expansion.

KEY COMPANIES AND RECENT MILESTONES

Philips (NL) (August 2025): Announced the launch of its latest oxygen concentrator model incorporating advanced AI technology to optimize oxygen delivery based on real-time patient data, setting a new standard for product functionality in the market. The company continues driving innovation through smart oxygen concentrators with portable and energy-efficient designs.

Invacare (US) (September 2025): Expanded its distribution network in Asia-Pacific, aiming to tap into the growing demand for home healthcare solutions in emerging markets. The company continues broadening its homecare oxygen solutions portfolio through acquisitions and product diversification.

AirSep (US) (July 2025): Entered into a strategic partnership with a leading telehealth provider to integrate remote monitoring capabilities into its oxygen concentrators, enabling continuous patient monitoring and timely interventions.

Other Key Players: OxyGo (US), Drive DeVilbiss Healthcare (GB), Nidek Medical (JP), GCE Group (SE), Precision Medical (US), Caire Inc. (US).

Future Outlook: 2025--2035

The Medical Oxygen Concentrators Market is projected to reach USD 7.0 billion by 2035, growing at a CAGR of 6.26%, driven by increasing respiratory diseases, technological advancements, and rising healthcare expenditures.

New opportunities lie in:

- Expansion into telehealth integration for remote monitoring solutions

- Development of portable oxygen concentrators for home healthcare markets

- Partnerships with hospitals for bulk procurement and service contracts

By 2035, the Medical Oxygen Concentrators Market is expected to achieve substantial growth and innovation.

Related Reports:

https://www.marketresearchfuture.com/press-release/cro-market

https://www.marketresearchfuture.com/press-release/ayurveda-industry

https://www.marketresearchfuture.com/press-release/medical-devices-market

https://www.marketresearchfuture.com/press-release/global-aesthetics-market

https://www.marketresearchfuture.com/press-release/africa-medical-devices-industry

https://www.marketresearchfuture.com/press-release/medical-tourism-market

https://www.marketresearchfuture.com/press-release/herbal-medicine-market

https://www.marketresearchfuture.com/press-release/corporate-wellness-market

https://www.marketresearchfuture.com/press-release/digital-mental-health-market

https://www.marketresearchfuture.com/press-release/contract-research-organization-market

https://www.marketresearchfuture.com/press-release/glp-1-drug-market

https://www.marketresearchfuture.com/press-release/health-supplements-market

https://www.marketresearchfuture.com/press-release/infection-control-market

https://www.marketresearchfuture.com/press-release/laboratory-equipment-market

https://www.marketresearchfuture.com/press-release/radiopharmaceutical-market

Market Research Future
Market Research Future
+1 855-661-4441
email us here